Jonathan Kil
Vorstandsvorsitzender bei Sound Pharmaceuticals, Inc.
Profil
Jonathan Kil is the founder.
He founded Otogene in 1998 and Sound Pharmaceuticals, Inc. in 2002, where he currently holds the title of Director, Chief Executive & Medical Officer.
Dr. Kil has a doctorate degree from the University of Virginia and an undergraduate degree from the University of California, Irvine.
Aktive Positionen von Jonathan Kil
| Unternehmen | Position | Beginn |
|---|---|---|
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 01.02.2002 |
Ehemalige bekannte Positionen von Jonathan Kil
| Unternehmen | Position | Ende |
|---|---|---|
| Otogene | Gründer | - |
Ausbildung von Jonathan Kil
| University of California, Irvine | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Otogene |
